Home / Latest Reports / Preimplantation Genetic Diagnosis Market

Preimplantation Genetic Diagnosis Market By Test Type and End User - Global Industry Analysis And Forecast To 2027

Published On : October 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC101355

Request Sample Inquiry Before Buying Request for Customization Check Discount

Preimplantation Genetic Diagnosis Market By Test Type (X-Linked Diseases, Single Gene Disorder, Gender Selection, Aneuploidy Screening, Hla Typing and Chromosomal Aberrations), and End User (Academic Institutes & Research Center, Health Care Facilities and Fertility Clinics), - Global Industry Analysis And Forecast To 2027

Industry Outlook

Preimplantation Genetic testing is used for identifying genetic defects in embryos developed through Vitro Fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) is done when one or both the hereditary parents have a known hereditary disorder and testing is performed on the embryo to determine whether it carries the same hereditary disorder. Preimplantation genetic diagnosis (PGD) has an advantage that it avoids abortion, as it determines that the bay is free from the known hereditary disorder. Preimplantation Genetic Diagnosis use is growing due to; increasing number of cases related to predominance of genetic, hereditary and chromosomal diseases, rising knowledge amongst the population about the avoidance of genetic disorders, etc. Therefore, the Preimplantation Genetic Diagnosis Market is anticipated to expand and has tremendous scope during the forecast period. The global Preimplantation Genetic Diagnosis Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Preimplantation Genetic Diagnosis Market is based on segment, by Test Type the market is segmented into X-Linked Diseases, Single Gene Disorder, Gender Selection, Aneuploidy Screening, Hla Typing and Chromosomal Aberrations, and by End User the market is segmented into Academic Institutes & Research Center, Health Care Facilities and Fertility Clinics.

  • Preimplantation Genetic Diagnosis Market, By Test Type
  • X-Linked Diseases
  • Single Gene Disorder
  • Gender Selection
  • Aneuploidy Screening
  • Hla Typing
  • Chromosomal Aberrations
  • Preimplantation Genetic Diagnosis Market, By End User
  • Academic Institutes & Research Center
  • Health Care Facilities
  • Fertility Clinics

Regional Insights

On a global front, the Preimplantation Genetic Diagnosis Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA).

Preimplantation Genetic Diagnosis Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Genesis Genetics Ltd., Thermo Fisher Scientific Inc., F. Hoffman-La-Roche Ltd, Reprogenetics, LLC, Natera Inc., Abbott Laboratories, Reproductive Genetics Innovations LLC, PerkinElmer Inc., Genea Limited, Quest Diagnostics Incorporated, Illumina, Inc. and Laboratory Corporation of America Holdings. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

    • Genesis Genetics Ltd.
    • Thermo Fisher Scientific Inc.
    • F. Hoffman-La-Roche Ltd
    • Reprogenetics, LLC
    • Natera Inc.
    • Abbott Laboratories
    • Reproductive Genetics Innovations LLC
    • PerkinElmer Inc.
    • Genea Limited
    • Quest Diagnostics Incorporated
    • Illumina, Inc.
    • Laboratory Corporation of America Holdings

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Preimplantation Genetic Diagnosis Market, By Test Type, Estimates and Forecast, 2017-2027 ($Million)

o   X-Linked Diseases

o   Single Gene Disorder

o   Gender Selection

o   Aneuploidy Screening

o   Hla Typing

o   Chromosomal Aberrations

·         Preimplantation Genetic Diagnosis Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o   Academic Institutes & Research Center

o   Health Care Facilities

o   Fertility Clinics

·         Preimplantation Genetic Diagnosis Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Preimplantation Genetic Diagnosis Market, By Country

o   U.S. Preimplantation Genetic Diagnosis Market

o   Canada Preimplantation Genetic Diagnosis Market

o   Mexico Preimplantation Genetic Diagnosis Market

o   Europe

§  Europe Preimplantation Genetic Diagnosis Market, By Country

o   Germany Preimplantation Genetic Diagnosis Market

o   UK Preimplantation Genetic Diagnosis Market

o   France Preimplantation Genetic Diagnosis Market

o   Russia Preimplantation Genetic Diagnosis Market

o   Italy Preimplantation Genetic Diagnosis Market

o   Rest of Europe Preimplantation Genetic Diagnosis Market

o   Asia-Pacific

§  Asia-Pacific Preimplantation Genetic Diagnosis Market, By Country

o   China Preimplantation Genetic Diagnosis Market

o   Japan Preimplantation Genetic Diagnosis Market

o   South Korea  Preimplantation Genetic Diagnosis Market

o   India Preimplantation Genetic Diagnosis Market

o   Southeast Asia Preimplantation Genetic Diagnosis Market

o   Rest of Asia-Pacific Preimplantation Genetic Diagnosis Market

o   South America

§  South America Preimplantation Genetic Diagnosis Market, By Country

o   Brazil Preimplantation Genetic Diagnosis Market

o   Argentina Preimplantation Genetic Diagnosis Market

o   Columbia Preimplantation Genetic Diagnosis Market

o   Rest of South America Preimplantation Genetic Diagnosis Market

o   Middle East and Africa

§  Middle East and Africa Preimplantation Genetic Diagnosis Market, By Country

o   Saudi Arabia Preimplantation Genetic Diagnosis Market

o   UAE Preimplantation Genetic Diagnosis Market

o   Egypt Preimplantation Genetic Diagnosis Market

o   Nigeria Preimplantation Genetic Diagnosis Market

o   South Africa Preimplantation Genetic Diagnosis Market

o   Rest of MEA Preimplantation Genetic Diagnosis Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Preimplantation Genetic Diagnosis Market, By Test Type

5.1.     Introduction

5.2.     Global Preimplantation Genetic Diagnosis Revenue and Market Share by Test Type (2017-2027)

5.2.1.  Global Preimplantation Genetic Diagnosis Revenue and Revenue Share by Test Type (2017-2027)

5.3.     X-Linked Diseases

5.3.1.  Global X-Linked Diseases Revenue and Growth Rate (2017-2027)

5.4.     Single Gene Disorder

5.4.1.  Global Single Gene Disorder Revenue and Growth Rate (2017-2027)

5.5.     Gender Selection

5.5.1.  Global Gender Selection Revenue and Growth Rate (2017-2027)

5.6.     Aneuploidy Screening

5.6.1.  Global Aneuploidy Screening Revenue and Growth Rate (2017-2027)

5.7.     Hla Typing

5.7.1.  Global Hla Typing Revenue and Growth Rate (2017-2027)

5.8.     Chromosomal Aberrations

5.8.1.  Global Chromosomal Aberrations Revenue and Growth Rate (2017-2027)

6.       Preimplantation Genetic Diagnosis Market, By End User

6.1.     Introduction

6.2.     Global Preimplantation Genetic Diagnosis Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Preimplantation Genetic Diagnosis Revenue and Revenue Share by End User (2017-2027)

6.3.     Academic Institutes & Research Center

6.3.1.  Global Academic Institutes & Research Center Revenue and Growth Rate (2017-2027)

6.4.     Health Care Facilities

6.4.1.  Global Health Care Facilities Revenue and Growth Rate (2017-2027)

6.5.     Fertility Clinics

6.5.1.  Global Fertility Clinics Revenue and Growth Rate (2017-2027)

7.       Preimplantation Genetic Diagnosis Market, By Region

7.1.     Introduction

7.2.     Global Preimplantation Genetic Diagnosis Revenue and Market Share by Regions

7.2.1.  Global Preimplantation Genetic Diagnosis Revenue by Regions (2017-2027)

7.3.     North America Preimplantation Genetic Diagnosis by Countries

7.3.1.  North America Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2027)

7.3.2.  North America Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Preimplantation Genetic Diagnosis by Countries

7.4.1.  Europe Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Preimplantation Genetic Diagnosis by Countries

7.5.1.  Asia-Pacific Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Preimplantation Genetic Diagnosis by Countries

7.6.1.  South America Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2027)

7.6.2.  South America Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Preimplantation Genetic Diagnosis by Countries

7.7.1.  Middle East and Africa Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Genesis Genetics Ltd.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Thermo Fisher Scientific Inc.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     F. Hoffman-La-Roche Ltd

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Reprogenetics, LLC

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Natera Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Abbott Laboratories

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Reproductive Genetics Innovations LLC

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     PerkinElmer Inc.

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Genea Limited

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Quest Diagnostics Incorporated

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

8.11. Illumina, Inc.

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.       Revenue and Market Share

8.12. Laboratory Corporation of America Holdings

8.12.1.      Business Overview

8.12.2.       Service Portfolio

8.12.3.      Strategic Developments

8.12.4.       Revenue and Market Share

9.       Global Preimplantation Genetic Diagnosis Market Competition, by Manufacturer

9.1.     Global Preimplantation Genetic Diagnosis Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Preimplantation Genetic Diagnosis Price By Region (2017-2017)

9.3.     Top 5 Preimplantation Genetic Diagnosis Manufacturer Market Share

9.4.     Market Competition Trend

10.    Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.1. Global Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Preimplantation Genetic Diagnosis Market Forecast by Regions (2017-2027)

10.2.1.      North America Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.1.1. United States Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.1.2. Canada Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.1.3. Mexico Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.2.      Europe Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.2.1. Germany Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.2.2. France Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.2.3. UK Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.2.4. Russia Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.2.5. Italy Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.3.1. China Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.3.2. Japan Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.3.3. Korea Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.3.4. India Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.4.      South America Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.4.1. Brazil Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.4.2. Argentina Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.4.3. Columbia Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.4.4. Rest of South America Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.5.3. Egypt Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.5.4. Nigeria Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.5.5. South Africa Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.5.6. Turkey Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Preimplantation Genetic Diagnosis Market Forecast (2017-2027)

10.3. Preimplantation Genetic Diagnosis Market Forecast by Test Type (2017-2027)

10.3.1.      Preimplantation Genetic Diagnosis Forecast by Test Type (2017-2027)

10.3.2.      Preimplantation Genetic Diagnosis Market Share Forecast by Test Type (2017-2027)

10.4. Preimplantation Genetic Diagnosis Market Forecast by End User (2017-2027)

10.4.1.      Preimplantation Genetic Diagnosis Forecast by End User (2017-2027)

10.4.2.      Preimplantation Genetic Diagnosis Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures
Figure United States Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Preimplantation Genetic Diagnosis Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Preimplantation Genetic Diagnosis Revenue and Revenue Share by Test Type (2017-2018)
Figure Global X-Linked Diseases Revenue and Growth Rate (2017-2018)
Figure Global Single Gene Disorder Revenue and Growth Rate (2017-2018)
Figure Global Gender Selection Revenue and Growth Rate (2017-2018)
Figure Global Aneuploidy Screening Revenue and Growth Rate (2017-2018)
Figure Global Hla Typing Revenue and Growth Rate (2017-2018)
Figure Global Chromosomal Aberrations Revenue and Growth Rate (2017-2018)
Table Global Preimplantation Genetic Diagnosis Revenue and Revenue Share by End User (2017-2018)
Figure Global Academic Institutes & Research Center Revenue and Growth Rate (2017-2018)
Figure Global Health Care Facilities Revenue and Growth Rate (2017-2018)
Figure Global Fertility Clinics Revenue and Growth Rate (2017-2018)
Table Global Preimplantation Genetic Diagnosis Revenue by Regions (2017-2018)
Figure North America Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure North America Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2018)
Figure North America Preimplantation Genetic Diagnosis by Countries (2017-2018)
Figure North America Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2018)
Figure United States Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure United States Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Canada Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Mexico Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Europe Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2018)
Figure Europe Preimplantation Genetic Diagnosis by Countries (2017-2018)
Figure Europe Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2018)
Figure Germany Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Germany Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure France Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure UK Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Russia Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Italy Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Rest of Europe Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Asia-Pacific Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Preimplantation Genetic Diagnosis by Countries (2017-2018)
Figure Asia-Pacific Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2018)
Figure China Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure China Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Japan Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Korea Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure India Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Southeast Asia Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure South America Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2018)
Figure South America Preimplantation Genetic Diagnosis by Countries (2017-2018)
Figure South America Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Brazil Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Argentina Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Columbia Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Rest of South America Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Middle East and Africa Preimplantation Genetic Diagnosis Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Preimplantation Genetic Diagnosis by Countries (2017-2018)
Figure Middle East and Africa Preimplantation Genetic Diagnosis Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Saudi Arabia Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure United Arab Emirates Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Egypt Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Nigeria Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure South Africa Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Turkey Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Preimplantation Genetic Diagnosis Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2017-2018)
Table Genesis Genetics Ltd. Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table F. Hoffman-La-Roche Ltd Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Reprogenetics, LLC Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Natera Inc. Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Reproductive Genetics Innovations LLC Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table PerkinElmer Inc. Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Genea Limited Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Quest Diagnostics Incorporated Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Illumina, Inc. Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Laboratory Corporation of America Holdings Preimplantation Genetic Diagnosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Preimplantation Genetic Diagnosis Market Share by Manufacturer
Figure Global Preimplantation Genetic Diagnosis Revenue and Market Share by Manufacturer
Table Global Preimplantation Genetic Diagnosis Price by Region (2017-2017)
Figure Top 5 Preimplantation Genetic Diagnosis Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Preimplantation Genetic Diagnosis Revenue (Millions USD) and Growth Rate (2018-2025)
Table Preimplantation Genetic Diagnosis Market Forecast by Regions (2018-2025)
Figure North America Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure United States Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Canada Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Mexico Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Europe Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Germany Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure France Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure UK Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Russia Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Italy Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Rest of Europe Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Asia-Pacific Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure China Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Japan Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Korea Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure India Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Southeast Asia Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure South America Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Brazil Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Argentina Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Columbia Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Rest of South America Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Middle East and Africa Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Saudi Arabia Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure United Arab Emirates Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Egypt Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Nigeria Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure South Africa Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Turkey Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Preimplantation Genetic Diagnosis Market Forecast (2018-2025)
Figure Global Preimplantation Genetic Diagnosis Forecast by Test Type (2018-2025)
Figure Global Preimplantation Genetic Diagnosis Market Share Forecast by Test Type (2018-2025)
Figure Global Preimplantation Genetic Diagnosis Forecast by Test Type (2018-2025)
Figure Global Preimplantation Genetic Diagnosis Forecast by End User (2018-2025)
Figure Global Preimplantation Genetic Diagnosis Market Share Forecast by End User (2018-2025)
Figure Global Preimplantation Genetic Diagnosis Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*